[go: up one dir, main page]

EE200300247A - Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena - Google Patents

Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena

Info

Publication number
EE200300247A
EE200300247A EEP200300247A EEP200300247A EE200300247A EE 200300247 A EE200300247 A EE 200300247A EE P200300247 A EEP200300247 A EE P200300247A EE P200300247 A EEP200300247 A EE P200300247A EE 200300247 A EE200300247 A EE 200300247A
Authority
EE
Estonia
Prior art keywords
isothiazole
antiproliferative agents
carboxamide salts
carboxamide
salts
Prior art date
Application number
EEP200300247A
Other languages
English (en)
Estonian (et)
Inventor
G. Gant Thomas
Robert Williams Glenn
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of EE200300247A publication Critical patent/EE200300247A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200300247A 2000-11-28 2001-11-19 Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena EE200300247A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25351300P 2000-11-28 2000-11-28
PCT/IB2001/002193 WO2002044158A1 (en) 2000-11-28 2001-11-19 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents

Publications (1)

Publication Number Publication Date
EE200300247A true EE200300247A (et) 2003-10-15

Family

ID=22960587

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300247A EE200300247A (et) 2000-11-28 2001-11-19 Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena

Country Status (49)

Country Link
US (1) US6831091B2 (es)
EP (1) EP1337521B1 (es)
JP (2) JP2004514714A (es)
KR (2) KR20050116401A (es)
CN (1) CN1231474C (es)
AP (1) AP2001002358A0 (es)
AR (1) AR031512A1 (es)
AT (1) ATE340786T1 (es)
AU (2) AU2002214204B2 (es)
BG (1) BG107752A (es)
BR (1) BR0115621A (es)
CA (1) CA2430065C (es)
CR (1) CR6963A (es)
CY (1) CY1106240T1 (es)
CZ (1) CZ20031315A3 (es)
DE (1) DE60123461T2 (es)
DK (1) DK1337521T3 (es)
DO (1) DOP2001000288A (es)
EA (1) EA005859B1 (es)
EC (1) ECSP034628A (es)
EE (1) EE200300247A (es)
ES (1) ES2271086T3 (es)
GE (1) GEP20053652B (es)
GT (1) GT200100237A (es)
HN (1) HN2001000268A (es)
HR (1) HRP20030408A2 (es)
HU (1) HUP0302553A3 (es)
IL (1) IL155371A0 (es)
IS (1) IS6788A (es)
MA (1) MA26960A1 (es)
MX (1) MXPA03004714A (es)
MY (1) MY136686A (es)
NO (1) NO325187B1 (es)
NZ (1) NZ525788A (es)
OA (1) OA12532A (es)
PA (1) PA8533801A1 (es)
PE (1) PE20020591A1 (es)
PL (1) PL362079A1 (es)
PT (1) PT1337521E (es)
SI (1) SI1337521T1 (es)
SK (1) SK5862003A3 (es)
SV (1) SV2002000748A (es)
TN (1) TNSN01167A1 (es)
TW (1) TWI287542B (es)
UA (1) UA74221C2 (es)
UY (1) UY27039A1 (es)
WO (1) WO2002044158A1 (es)
YU (1) YU36403A (es)
ZA (1) ZA200303341B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
ME00275B (me) 1999-01-13 2011-02-10 Bayer Corp ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
JP2002534468A (ja) 1999-01-13 2002-10-15 バイエル コーポレイション ｐ３８キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
PT1478358E (pt) 2002-02-11 2013-09-11 Bayer Healthcare Llc Tosilato de sorafenib para o tratamento de doenças caracterizadas por angiogénese anormal
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
CA2493701A1 (en) * 2002-07-25 2004-02-05 Pfizer Products Inc. Isothiazole derivatives useful as anticancer agents
BR0313593A (pt) * 2002-08-19 2005-07-12 Pfizer Prod Inc Terapia de combinação para doenças hiperproliferativas
DK1636585T3 (da) 2003-05-20 2008-05-26 Bayer Pharmaceuticals Corp Diarylurinstoffer med kinasehæmmende aktivitet
PT1663978E (pt) 2003-07-23 2008-02-15 Bayer Pharmaceuticals Corp Omega-carboxiaril difenil ureia substituída por flúor para o tratamento e a prevenção de doenças e estados patológicos
CA2543201C (en) * 2003-10-27 2010-12-21 Merck & Co., Inc. ((ir, 3s)-3-isopropyl-3-{ [3-(trifluoromethyl)-7, 8-dihydro-1, 6-naphthyridin-6 (5h)-yl] carbonyl} cyclopentyl) [(3s, 4s)-3-methoxytetrahydro-2h-pyran-4-yl] amine succinate salt, composition thereof, and its use in the treatment of inflammatory diseases
EP1694686A1 (en) 2003-12-19 2006-08-30 Takeda San Diego, Inc. Kinase inhibitors
WO2005102327A1 (en) * 2004-04-20 2005-11-03 Pfizer Products Inc. Dosage forms and methods of treatment using vegfr inhibitors
MXPA06012394A (es) 2004-04-30 2007-01-31 Bayer Pharmaceuticals Corp Derivados de pirazolilurea sustituidos utiles en el tratamiento de cancer.
TW200538104A (en) * 2004-05-17 2005-12-01 Pfizer Prod Inc Phenyl derivatives for the treatment of abnormal cell growth
EP1778669A2 (en) 2004-08-18 2007-05-02 Takeda San Diego, Inc. Kinase inhibitors
DE602005023333D1 (de) 2004-10-15 2010-10-14 Takeda Pharmaceutical Kinaseinhibitoren
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
ZA200810017B (en) 2006-06-16 2010-04-28 Lundbeck & Co As H 1- [2- (2, 4-Dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin Reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
US7932390B2 (en) 2006-06-29 2011-04-26 Hoffman-La Roche Inc. Substituted thieno[3,2-C]pyridine carboxylic acid derivatives
EA200970361A1 (ru) 2006-10-09 2010-02-26 Такеда Фармасьютикал Компани Лимитед Ингибиторы киназы
MX2010001636A (es) 2007-08-14 2010-03-15 Hoffmann La Roche Derivados de pirazolo[3,4-d]-pirimidina como agentes antiproliferativos.
WO2011073521A1 (en) 2009-12-15 2011-06-23 Petri Salven Methods for enriching adult-derived endothelial progenitor cells and uses thereof
SG187592A1 (en) 2010-07-23 2013-03-28 Univ Boston Anti-despr inhibitors as therapeutics for inhibition of pathological angiogenesis and tumor cell invasiveness and for molecular imaging and targeted delivery
TR201901462T4 (tr) 2013-03-14 2019-02-21 Panoptica Inc Gözün posterior segmentine ilaç uygulanması için oküler formülasyonlar.
AU2015317531B2 (en) * 2014-09-17 2020-11-19 Panoptica, Inc. Ocular formulations for drug-delivery and protection of the anterior segment of the eye
AU2023416218A1 (en) * 2022-12-28 2025-07-10 Beyang Therapeutics Co., Ltd. Protein tyrosine kinase inhibitor and medical use thereof
WO2026002142A1 (zh) * 2024-06-27 2026-01-02 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂的半琥珀酸盐晶型
WO2026002133A1 (zh) * 2024-06-27 2026-01-02 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂的盐型
WO2026002126A1 (zh) * 2024-06-27 2026-01-02 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂及其眼用制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця

Also Published As

Publication number Publication date
UA74221C2 (uk) 2005-11-15
PA8533801A1 (es) 2002-10-31
ES2271086T3 (es) 2007-04-16
MY136686A (en) 2008-11-28
ATE340786T1 (de) 2006-10-15
JP2008056692A (ja) 2008-03-13
GT200100237A (es) 2002-07-03
HN2001000268A (es) 2002-01-30
DE60123461D1 (de) 2006-11-09
EA005859B1 (ru) 2005-06-30
MXPA03004714A (es) 2003-08-19
DOP2001000288A (es) 2002-12-15
BR0115621A (pt) 2003-09-02
AU1420402A (en) 2002-06-11
DE60123461T2 (de) 2007-02-15
NO20032388L (no) 2003-07-18
KR20050116401A (ko) 2005-12-12
CN1231474C (zh) 2005-12-14
AP2001002358A0 (en) 2001-12-31
UY27039A1 (es) 2002-07-31
SV2002000748A (es) 2002-12-02
IL155371A0 (en) 2003-11-23
OA12532A (en) 2006-06-02
IS6788A (is) 2003-04-14
JP2004514714A (ja) 2004-05-20
NO325187B1 (no) 2008-02-11
SI1337521T1 (sl) 2006-12-31
PL362079A1 (en) 2004-10-18
HK1059085A1 (en) 2004-06-18
AU2002214204B2 (en) 2007-05-24
YU36403A (sh) 2006-08-17
NZ525788A (en) 2004-11-26
NO20032388D0 (no) 2003-05-27
US6831091B2 (en) 2004-12-14
TNSN01167A1 (fr) 2005-11-10
EP1337521A1 (en) 2003-08-27
HUP0302553A3 (en) 2009-03-30
CN1476439A (zh) 2004-02-18
HRP20030408A2 (en) 2003-08-31
CZ20031315A3 (cs) 2004-04-14
PT1337521E (pt) 2006-12-29
HUP0302553A2 (hu) 2003-11-28
PE20020591A1 (es) 2002-07-06
DK1337521T3 (da) 2007-01-29
WO2002044158A1 (en) 2002-06-06
CY1106240T1 (el) 2011-06-08
KR20030059275A (ko) 2003-07-07
JP4971946B2 (ja) 2012-07-11
GEP20053652B (en) 2005-11-10
ECSP034628A (es) 2003-07-25
MA26960A1 (fr) 2004-12-20
BG107752A (bg) 2004-01-30
CA2430065A1 (en) 2002-06-06
SK5862003A3 (en) 2004-05-04
US20020151573A1 (en) 2002-10-17
CA2430065C (en) 2008-05-20
EA200300424A1 (ru) 2003-10-30
TWI287542B (en) 2007-10-01
CR6963A (es) 2003-11-25
ZA200303341B (en) 2004-04-30
EP1337521B1 (en) 2006-09-27
AR031512A1 (es) 2003-09-24

Similar Documents

Publication Publication Date Title
EE200300247A (et) Isotiasool-4-karboksamiidi soolad ja nende kasutamine hüperproliferatsioonivastaste vahenditena
EE05350B1 (et) Antiproliferatiivsete vahenditena kasutatavad bensoimidasooli derivaadid
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
EE200200341A (et) Asendatud oksasolidinoonid ja nende kasutamine
DE60137897D1 (de) Absorbierender Artikel
DE60112221D1 (de) Absorbierender Artikel
DE60140977D1 (de) Absorbierender artikel
DE60104745D1 (de) Absorbierender Artikel
DE60114289D1 (de) Absorbierender Artikel
DE60139744D1 (de) Absorbierender artikel
DE60108385D1 (de) Absorbierender artikel
EE200200550A (et) Karbamaatsed kaspaasi inhibiitorid ja nende kasutamine
DE60142945D1 (de) Absorbierender Artikel
DE60117928D1 (de) Saugfähiger Artikel
ATE267178T1 (de) Diazepinderivate oder deren salze
DE60139432D1 (de) Absorbierender Artikel
DE60140838D1 (de) Saugfähiger Gegenstand
DE60141727D1 (de) Absorbierender artikel
DE60137738D1 (de) Absorbierender Artikel
DE60111909D1 (de) Absorbierender Artikel
DE50104507D1 (de) Reinigungs- und desinfektionsmittel
NO20025510L (no) Dibenzoazulen-derivater samt anvendelse derav
DE60103683D1 (de) Wässrige Pestizidzusammensetzung
BR0113783B1 (pt) Composição aquosa
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate